Featured Research

from universities, journals, and other organizations

Vaccines preventing pneumococcal disease protect African children with sickle-cell disease

Date:
April 28, 2010
Source:
Johns Hopkins University Bloomberg School of Public Health
Summary:
A new study finds that African children who contract pneumococcus -- a bacterial infection that causes pneumonia, meningitis and sepsis -- are 36 times as likely to have sickle-cell disease, a blood disorder prevalent in African children that increases the risk for infectious diseases and early death.

A new study in The Lancet Infectious Diseases finds that African children who contract pneumococcus -- a bacterial infection that causes pneumonia, meningitis and sepsis -- are 36 times as likely to have sickle-cell disease, a blood disorder prevalent in African children that increases the risk for infectious diseases and early death. The study underscores the critical need for use of pneumococcal conjugate vaccines (PCV) among populations predisposed to sickle-cell disease, most notably those in sub-saharan Africa.

Related Articles


"Our findings clearly show that African children with sickle-cell disease are at increased risk of bacterial illness compared with their peers without sickle-cell disease, with the pneumococcus being of particular concern," said Dr. Keith P. Klugman, contributing author and professor and William H. Foege Chair in Global Health at the Rollins School of Public Health.

Africa is home to the vast majority of the world's sickle-cell disease cases. Sickle-cell disease is inherited by a child from both parents and is caused by abnormal hemoglobin, a blood protein that distorts the shape of red blood cells and delivers less oxygen to tissues. The disease weakens the immune system and puts its victims at risk for serious bacterial infection and childhood death. Data examined from studies in the Democratic Republic of the Congo, Nigeria, Kenya and Senegal -- countries with the highest sickle-cell disease burden -- clearly demonstrate an increased risk of serious bacterial infection, especially invasive pneumococcal disease, in African children with sickle-cell disease.

"In combination with early diagnosis and treatment of sickle-cell disease, routine, country-wide immunization against pneumococcus is the best strategy to improve quality of life for all African children, particularly those with sickle-cell disease," said Orin Levine, contributing author, executive director of the International Vaccine Access Center (IVAC) at The Johns Hopkins Bloomberg School of Public Health and co-chair of the Pneumococcal Awareness Council of Experts (PACE). "Millions of lives can be saved by improving access to pneumococcal conjugate vaccines."

One-third of all indigenous inhabitants of Sub-Saharan Africa carry the sickle cell gene, and approximately, 230,000 African children are born with sickle-cell disease each year. Because routine access to medical care is out of reach for many children in the region, the average life expectancy for those afflicted with sickle cell disease in Africa is less than 20 years. In many developed countries where comprehensive care including pneumococcal vaccination and aggressive treatment are available, life-expectancy for sickle cell patients is 45-55 years. Since PCV was first introduced in 2000 in the United States, invasive pneumococcal infections in children with sickle-cell disease declined 68 percent in children under 10 and by 90 percent in children under five.

"The one-two punch of sickle-cell disease coupled with pneumococcal disease is devastating in Africa making protecting Africa's children through vaccination an urgent priority," said Ciro A. de Quadros executive vice president of the Sabin Vaccine Institute and co-chair of PACE. "We urge the leaders of African countries to make routine vaccination against pneumococcal disease a priority."

Pneumococcal disease is a bacterial infection that causes life-threatening pneumonia, meningitis and sepsis. Every year, pneumococcal disease takes the lives of nearly 1.6 million people, nearly half of whom are young children in the developing world, where vaccines to prevent the disease are not yet in widespread use. The lack of access in these countries has been due primarily to obstacles in awareness, policy guidance and available financing for low-income countries.

Safe and effective vaccines currently exist to prevent pneumococcal deaths. In 2006, the World Health Organization (WHO) recommended that all countries include PCV in their national immunization programs, especially in countries where childhood mortality is high. The WHO recommendation guides country policy-making on the prioritization of measures to address childhood pneumococcal disease.

The Pneumococcal Awareness Council of Experts (PACE), a project of the Sabin Vaccine Institute, is comprised of leading global experts in infectious diseases and vaccines. The Council raises awareness among policy-makers and aims to secure global commitments to prevent pneumococcal disease, a leading infectious killer of children and adults worldwide. The Council works through collaboration and partnership with countries, NGOs, academia and industry to achieve its goals. To learn more, visit www.sabin.org/PACE.


Story Source:

The above story is based on materials provided by Johns Hopkins University Bloomberg School of Public Health. Note: Materials may be edited for content and length.


Journal Reference:

  1. Meenakshi Ramakrishnan, Jennifer C Moïsi, Keith P Klugman, Jesus M Feris Iglesias, Lindsay R Grant, Mireille Mpoudi-Etame, Orin S Levine. Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis. The Lancet Infectious Diseases, 2010; 10 (5): 329 DOI: 10.1016/S1473-3099(10)70055-4

Cite This Page:

Johns Hopkins University Bloomberg School of Public Health. "Vaccines preventing pneumococcal disease protect African children with sickle-cell disease." ScienceDaily. ScienceDaily, 28 April 2010. <www.sciencedaily.com/releases/2010/04/100428110804.htm>.
Johns Hopkins University Bloomberg School of Public Health. (2010, April 28). Vaccines preventing pneumococcal disease protect African children with sickle-cell disease. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2010/04/100428110804.htm
Johns Hopkins University Bloomberg School of Public Health. "Vaccines preventing pneumococcal disease protect African children with sickle-cell disease." ScienceDaily. www.sciencedaily.com/releases/2010/04/100428110804.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins